Graphique du cours de l'action HLOSF
HLOSF Gagner
Healios K.K.
$1.8
0%
$0
À partir d'aujourd'hui :Aug 06, 10:23:44 GMT-4
Retour
Healios K.K. (HLOSF) Gagner
Statistiques clés
Clôture préc.
$1.8
Prix d'ouverture
$1.8
Plage de la journée
$1.8 - $1.8
Plage de 52 semaines
$1.8 - $4.45
Volume
100
Volume moyen
20
Rendement en dividend
--
BPA (TTM)
-0.16
Capitalisation boursière
$243.0M
Qu’est-ce que HEALIOS K K ?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 75 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Fonctionnalités
© 2026 Edgen fonctionné par